Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net (loss) income	$ (1,234)	$ 4,192
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization	1,731	557
Amortization of operating lease-right-of use assets	2,064	0
Stock-based compensation	12,130	3,578
Gain on equity method investment	0	(40)
Provision for excess and obsolete inventory	462	333
Interest expenses for accretion of the legal settlement liabilities	1,611	1,215
Change in operating assets and liabilities:
Trade accounts receivable	(11,780)	(11,647)
Inventories	(19,537)	(4,838)
Prepaid expenses and other assets	(15,035)	(5,002)
Trade accounts payable	2,770	486
Accrued expenses and other liabilities	2,828	2,099
Legal settlement liabilities	478	1,612
Deferred revenue	6,496	6,637
Lease liabilities	(1,408)	0
Net cash used in operating activities	(18,424)	(818)
Cash flows from investing activities:
Purchase of property and equipment	(3,218)	(3,068)
Purchase of intangible assets (patents)	(40)
Payment for investment	(1,587)	0
Payment for additional investment in Cytek Japan, net of cash acquired	0	371
Net cash used in investing activities	(4,845)	(2,697)
Cash flows from financing activities:
Repayment of Paycheck Protection Program loan	0	(2,772)
Proceeds from Issuance Initial Public Offering	0	215,689
Proceeds from Employee Stock Purchase Plan	765	0
Payments for taxes related to net share settlement of equity awards	(138)	0
Proceeds from issuance of common stock under employee stock plans	1,036	625
Net cash provided by financing activities	1,663	213,542
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(1,489)	625
Cash, cash equivalents and restricted cash:
Net (decrease) increase in cash, cash equivalents and restricted cash	(23,095)	(210,652)
Cash, cash equivalents and restricted cash at beginning of period	364,618	166,119
Cash, cash equivalents and restricted cash at end of period	341,523	376,771
Supplemental disclosure of cash flow information:
Cash paid for taxes	9,930	2,238
Non-cash investing and financing activities:
Fixed asset purchases in accounts payable at period end	235	309
Intangible asset in accrued expenses at period end	$ 69	$ 90